FDA — authorised 18 February 2014
- Application: NDA203202
- Marketing authorisation holder: LUNDBECK NA LTD
- Local brand name: NORTHERA
- Indication: CAPSULE — ORAL
- Status: approved
🇺🇸 Droxidopa capsules in United States
FDA authorised Droxidopa capsules on 18 February 2014
Marketing authorisations
FDA
- Status: approved
Droxidopa capsules in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Frequently asked questions
Is Droxidopa capsules approved in United States?
Yes. FDA authorised it on 18 February 2014; FDA has authorised it.
Who is the marketing authorisation holder for Droxidopa capsules in United States?
LUNDBECK NA LTD holds the US marketing authorisation.